Aeterna Zentaris Stock Price, News & Analysis
Company Description
Aeterna Zentaris (NASDAQ: AEZS) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $17.5M, ranking #6,168 among all listed U.S. companies by market cap.
AEZS stock has declined 63.1% over the past year. Shares last traded at $5.43.
This page provides a comprehensive overview of AEZS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aeterna Zentaris (AEZS) stock last traded at $5.43. Over the past 12 months, the stock has lost 63.1%. At a market capitalization of $17.5M, AEZS is classified as a micro-cap stock with approximately 3.1M shares outstanding.
Latest News
Aeterna Zentaris has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, earnings. View all AEZS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AEZS Company Profile & Sector Positioning
Aeterna Zentaris (AEZS) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.